AU2001289284A1 - Methods for identifying peptide aptamers capable of altering a cell phenotype - Google Patents

Methods for identifying peptide aptamers capable of altering a cell phenotype

Info

Publication number
AU2001289284A1
AU2001289284A1 AU2001289284A AU8928401A AU2001289284A1 AU 2001289284 A1 AU2001289284 A1 AU 2001289284A1 AU 2001289284 A AU2001289284 A AU 2001289284A AU 8928401 A AU8928401 A AU 8928401A AU 2001289284 A1 AU2001289284 A1 AU 2001289284A1
Authority
AU
Australia
Prior art keywords
altering
methods
cell phenotype
peptide aptamers
identifying peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289284A
Inventor
John D. Benson
Bradley Bryan Brasher
Sylvie Magali Vincent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enanta Pharmaceuticals Inc
Original Assignee
Enanta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharmaceuticals Inc filed Critical Enanta Pharmaceuticals Inc
Publication of AU2001289284A1 publication Critical patent/AU2001289284A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
AU2001289284A 2000-04-04 2001-04-04 Methods for identifying peptide aptamers capable of altering a cell phenotype Abandoned AU2001289284A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19472200P 2000-04-04 2000-04-04
US60/194722 2000-04-04
PCT/US2001/010953 WO2001075178A2 (en) 2000-04-04 2001-04-04 Methods for identifying peptide aptamers capable of altering a cell phenotype

Publications (1)

Publication Number Publication Date
AU2001289284A1 true AU2001289284A1 (en) 2001-10-15

Family

ID=22718675

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289284A Abandoned AU2001289284A1 (en) 2000-04-04 2001-04-04 Methods for identifying peptide aptamers capable of altering a cell phenotype

Country Status (3)

Country Link
US (1) US20030108532A1 (en)
AU (1) AU2001289284A1 (en)
WO (1) WO2001075178A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
US20030134329A1 (en) * 2001-10-09 2003-07-17 Thea Norman Cross-species bioactive peptides
WO2003040168A2 (en) * 2001-11-06 2003-05-15 Enanta Pharmaceuticals, Inc. Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
JP2005529624A (en) * 2002-06-21 2005-10-06 シノゲノマックス カンパニー リミテッド Random DNA library and double-stranded RNA library, its use and production method
US20050052687A1 (en) * 2003-08-12 2005-03-10 Murata Kikai Kabushiki Kaisha Image processing device and communication terminal device
CA2568644C (en) * 2004-06-03 2015-11-24 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
US20110150885A1 (en) 2009-12-11 2011-06-23 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CN103097524B (en) 2010-04-28 2016-08-03 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Alanyl-tRNA synthetase finds
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
CN103118693B (en) 2010-04-29 2017-05-03 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
CN103096925A (en) 2010-05-03 2013-05-08 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases
ES2668207T3 (en) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to fragments of methionyl-tRNA synthetases proteins
WO2011140132A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
US9062302B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
CA3090304A1 (en) 2010-05-13 2011-11-17 Sarepta Therapeutics, Inc. Antisense modulation of interleukins 17 and 23 signaling
CN103200953B (en) 2010-05-14 2017-02-15 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
AU2011258106B2 (en) 2010-05-27 2017-02-23 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
EP2970433B1 (en) 2013-03-13 2019-09-18 Bioasis Technologies Inc. Fragments of p97 and uses thereof
US20210355468A1 (en) 2020-05-18 2021-11-18 Bioasis Technologies, Inc. Compositions and methods for treating lewy body dementia
US20210393787A1 (en) 2020-06-17 2021-12-23 Bioasis Technologies, Inc. Compositions and methods for treating frontotemporal dementia
WO2024044770A1 (en) 2022-08-26 2024-02-29 Core Biotherapeutics, Inc. Oligonucleotides for the treatment of breast cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528266A (en) * 1979-10-01 1985-07-09 George Pieczenik Method of inserting unique DNA sequences into DNA vectors
DE3590766C2 (en) * 1985-03-30 1991-01-10 Marc Genf/Geneve Ch Ballivet
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US4980281A (en) * 1988-02-10 1990-12-25 Housey Gerard M Method of screening for protein inhibitors and activators
US5688655A (en) * 1988-02-10 1997-11-18 Ict Pharmaceuticals, Inc. Method of screening for protein inhibitors and activators
US5136779A (en) * 1989-09-27 1992-08-11 Die Tech, Inc. Method of mounting lead frame on substrate
US5639595A (en) * 1990-05-01 1997-06-17 Isis Phamaceuticals, Inc. Identification of novel drugs and reagents
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
US5753432A (en) * 1990-10-19 1998-05-19 Board Of Trustees Of The University Of Illinois Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
US5665550A (en) * 1990-10-19 1997-09-09 Board Of Trustees Of The University Of Illinois-Urbana Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
US5830725A (en) * 1995-04-28 1998-11-03 The Board Of Trustees For The Leland Stanford Junior University Rapid, stable high-titre production of recombing retrovirus
JPH11505724A (en) * 1995-06-02 1999-05-25 エム・アンド・イー・バイオテク・エー／エス Methods for identifying biologically active peptides and nucleic acids
AU1707497A (en) * 1996-01-23 1997-08-20 Rigel Pharmaceuticals, Inc. Methods for screening for transdominant intracellular effector peptides and rna molecules
US5955275A (en) * 1997-02-14 1999-09-21 Arcaris, Inc. Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
US6025485A (en) * 1997-02-14 2000-02-15 Arcaris, Inc. Methods and compositions for peptide libraries displayed on light-emitting scaffolds
US5998136A (en) * 1996-08-19 1999-12-07 Arcaris, Inc. Selection systems and methods for identifying genes and gene products involved in cell proliferation
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
US6071691A (en) * 1998-04-27 2000-06-06 Oregon Health Science University Materials and methods for modulating differentiation
US6180343B1 (en) * 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides

Also Published As

Publication number Publication date
US20030108532A1 (en) 2003-06-12
WO2001075178A2 (en) 2001-10-11
WO2001075178A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001289284A1 (en) Methods for identifying peptide aptamers capable of altering a cell phenotype
AU2002361589A1 (en) Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
AU2001258771A1 (en) -secretase inhibitors
AU2001237041A1 (en) Kinase inhibitors
AU2002230669A1 (en) Postmortem stem cells
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001290078A1 (en) Stem cell therapy
AU2001235988A1 (en) Solenoid
AU2002222627A1 (en) Tak1 inhibitors
IL153230A0 (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
AUPQ529000A0 (en) Toner characterization cell
AU2002210884A1 (en) Method for determining mass altering moiety in peptides
AU2002328803A1 (en) Marker for identifying hematopoietic stem cells
AU2001294010A1 (en) Stem cells
AU2001295966A1 (en) Cell damage inhibitor
AU2002212184A1 (en) Methods and reagents for protease inhibition
AU2001227708A1 (en) Methods for identifying inhibitors of neuronal degeneration
AU2001278997A1 (en) Thrombin inhibitors
AU2002352320A1 (en) Method for enhancing keratinocyte stem cells
AU5647501A (en) Crystallography methods
AU2001268040A1 (en) Methods and compounds for inhibiting mrp1
AU2001282520A1 (en) Grk inhibitor
AU2002214919A1 (en) Mutant trichosanthin
AU2001233965A1 (en) Novel cd23 inhibitors